Abstract
The ProTide prodrug technology has proved very useful in the discovery of nucleotide therapeutics and has successfully led to two FDA-approved drugs. However, with the extensive application of this prodrug approach to nucleotides for nearly three decades, the intellectual property (IP) landscape is becoming congested and, to overcome this, new inventive applications of the ProTide prodrug technology are emerging.
Cite
CITATION STYLE
Alanazi, A. S., James, E., & Mehellou, Y. (2019, October 1). The ProTide Prodrug Technology: Where Next? ACS Medicinal Chemistry Letters. American Chemical Society. https://doi.org/10.1021/acsmedchemlett.8b00586
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.